Transcriptome analysis of early pregnancy vitamin D status and spontaneous preterm birth.

What Was Tested

The paper reports a study of Vitamin D, K2, Magnesium and Zinc, published as a randomized controlled trial.

The researchers further constructed a network of these gene signatures and identified the common biological pathways involved.

Why It Was Studied

The researchers conducted a literature review on the studies that investigated the relationship of preterm birth, including spontaneous preterm birth (sPTB), with vitamin D status.

However, the potential mechanisms and biological pathways are unknown.

Who Took Part

The study group was 24 women.

PubMed indexes the participants as young adults and adults, women only.

In this cohort, 8 women had spontaneous preterm delivery (21-32 weeks of gestation) and 17 women had vitamin D insufficiency (25-hydroxyvitamin D < 30 ng/mL).

How the Study Was Run

In design terms this was a randomized and double-blind study.

The women were allocated by chance, so the Vitamin D, K2, Magnesium and Zinc group and the comparison group should start out alike.

Blinding on both sides kept the women and researchers unaware of who received Vitamin D, K2, Magnesium and Zinc.

The researchers separately identified vitamin D-associated and sPTB gene signatures at 10 to 18 weeks and replicated the overlapping signatures in the mid-pregnancy peripheral blood of an independent cohort with sPTB cases.

What Was Measured

Topics PubMed links to this paper include Case-Control Studies, Cohort Studies, Gene Expression Profiling, Incidence, Maternal Health, Premature Birth and Protein Interaction Maps.

What This Means in Plain Language

The paper is a randomized and double-blind study of Vitamin D, K2, Magnesium and Zinc in 24 women.

With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.

Its findings take up roughly 4 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2020 (PloS one), a journal based in United States.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.